A compounding business continues to compound problems for AmerisourceBergen (ABC), one of the nation’s largest pharmaceutical wholesalers.
The company disclosed that it remains unclear when its Pharmedium Services unit would resume shipments from a key facility in Memphis, thanks to an ongoing review by the Food and Drug Administration, according to a new regulatory filing. This is a major reversal from an upbeat forecast delivered just two months ago, when AmerisourceBergen indicated distribution would get under way before the end of September.
About the Author Reprints
